Invention Grant
- Patent Title: Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subject
-
Application No.: US14983324Application Date: 2015-12-29
-
Publication No.: US09751924B2Publication Date: 2017-09-05
- Inventor: Lei Ling , Darrin Anthony Lindhout
- Applicant: NGM Biopharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: NGM Biopharmaceuticals, Inc.
- Current Assignee: NGM Biopharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Jones Day
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/50 ; G01N33/50 ; A61K31/14 ; A61K31/155 ; A61K45/06 ; A61K31/785 ; A61K38/00
Abstract:
The invention relates to methods for and uses in reducing glucose levels in subjects in need thereof with variants and fusions of fibroblast growth factor 19 (FGF19) proteins and peptide sequences (and peptidomimetics).
Public/Granted literature
Information query
IPC分类:
